GlassScriptPhysician profile
David L Hurt
NPI 1134237928
$7,111.40
in general payments reported to CMS, 2019-2025
34 companies · $768 in 2025
The $768 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $629 · 2021: $1,281 · 2022: $980 · 2023: $1,183 · 2024: $1,147 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,923 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,922.80 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,755.11 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $620.47 | 2019-2025 | Blu-U, Odomzo, Winlevi |
| Janssen Biotech, INC. | $608.11 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Allergan, INC. | $564.15 | 2019-2022 | |
| Galderma Laboratories, L.P. | $381.38 | 2019-2025 | Nemluvio, Aklief |
| Regeneron Healthcare Solutions, INC. | $311.13 | 2019-2025 | Dupixent, Libtayo |
| Pfizer INC. | $284.73 | 2019-2023 | |
| Leo Pharma INC. | $274.66 | 2019-2022 | |
| Kerecis Limited | $270.13 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Novartis Pharmaceuticals Corporation | $245.51 | 2019-2025 | |
| Ucb, INC. | $245.12 | 2021-2025 | Cimzia, Bimzelx |
| Genzyme Corporation | $210.79 | 2019-2024 | |
| Incyte Corporation | $203.72 | 2022-2025 | Opzelura |
| Amgen INC. | $196.07 | 2019-2025 | Otezla |
| Lilly USA, LLC | $160.55 | 2019-2023 | Olumiant, Taltz |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $88.29 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $85.91 | 2022-2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $80.81 | 2021-2023 | Jublia |
| Epi Health, LLC | $78.56 | 2019 | |
| Dusa Pharmaceuticals, INC. | $68.51 | 2019 | |
| Organogenesis INC. | $64.88 | 2023-2025 | Cygnus Dual, Puraply |
| Biowound Solutions, INC. | $37.75 | 2025 | Bio-Connekt |
| Dermavant Sciences, INC. | $36.34 | 2024 | Vtama |
| Genentech USA, INC. | $34.53 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $34.33 | 2019 | |
| Organon LLC | $26.61 | 2023 | Hadlima |
| Merz North America, INC. | $25.02 | 2019 | |
| Dermira, INC. | $23.51 | 2019 | |
| Almirall LLC | $22.08 | 2021 | |
| Arcutis Biotherapeutics, INC. | $18.26 | 2024 | Zoryve |
| Aclaris Therapeutics, INC. | $17.95 | 2019 | |
| Celgene Corporation | $16.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.27 | 2023 | Spevigo |
| Journey Medical Corporation | $3.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hurt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.